| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 77116990 | FILING DATE | 02/27/2007 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | LEHKER, DAWN FELDMAN |
L.O. ASSIGNED | 111 |
PUB INFORMATION |
|||
| RUN DATE | 12/18/2007 | ||
| PUB DATE | 01/22/2008 | ||
| STATUS | 681-PUBLICATION/ISSUE REVIEW COMPLETE | ||
| STATUS DATE | 12/17/2007 | ||
| LITERAL MARK ELEMENT | CHANEX | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | YES | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | CHANEX |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | OXFORD BIOMEDICA PLC |
| ADDRESS | THE OXFORD SCIENCE PARK MEDAWAR CENTRE, ROBERT ROBINSON AVENUE OXFORD, OX44GA |
| ENTITY | 11-COMPANY |
| CITIZENSHIP | United Kingdom |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPUETIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACID FOR USE IN THE TREATMENT OF CANCER, HIV AND AIDS-RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS, VIRAL AND BACTIERIAL DISEASES, CANCER AND CYSTIC FIBROSIS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACUETICAL PREPARATIONS FOR THE TREATMENT OF CYSTIC FIBROSIS |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS, NAMELY, SYRINGES, SCALPELS, CATHETERS AND TUBES FOR MEDICAL SERVICES |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | genetic engineering services and biotechnology services, namely, development and commercialization of therapeutic vaccines and gene-based therapies in respect of oncology and neurotherapy |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| OWNER OF US REG NOS | 2437902 |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | N/A |
| APPLICATION NO. | N/A |
| APPLICATION FILING DATE | N/A |
| FOREIGN REG NO. | 000850222 |
| FOREIGN REG DATE | 11/17/1999 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 12/06/2008 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/17/2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 010 |
| 12/17/2007 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | 009 |
| 12/13/2007 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | 008 |
| 12/13/2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 007 |
| 12/13/2007 | ALIE | A | ASSIGNED TO LIE | 006 |
| 11/05/2007 | I | PAPER RECEIVED | 005 | |
| 05/11/2007 | GNRT | F | NON-FINAL ACTION E-MAILED | 004 |
| 05/11/2007 | CNRT | R | NON-FINAL ACTION WRITTEN | 003 |
| 05/09/2007 | DOCK | D | ASSIGNED TO EXAMINER | 002 |
| 03/02/2007 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Howard N. Aronson |
| CORRESPONDENCE ADDRESS | HOWARD N. ARONSON LACKENBACH SIEGEL LLP 1 CHASE RD SCARSDALE, NY 10583-4156 |
| DOMESTIC REPRESENTATIVE | Howard N. Aronson |